Safety of Effivia ®, a Bevacizumab Biosimilar
Conditions: Metastatic Colorectal Cancer; Metastatic Cervical Cancer; Non Squamous Non Small Cell Lung Cancer Interventions: Drug: Bevacizumab Biosimilar MB02 Sponsors: Laboratorios Liomont; Servicios Especializados en Ensayos Cl ínicos, S.C. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avastin | Cancer | Cancer & Oncology | Cervical Cancer | Colorectal Cancer | Lung Cancer | Non-Small Cell Lung Cancer | Research